CN103936833A - BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白 - Google Patents
BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白 Download PDFInfo
- Publication number
- CN103936833A CN103936833A CN201410158687.1A CN201410158687A CN103936833A CN 103936833 A CN103936833 A CN 103936833A CN 201410158687 A CN201410158687 A CN 201410158687A CN 103936833 A CN103936833 A CN 103936833A
- Authority
- CN
- China
- Prior art keywords
- blys
- fusion protein
- antagonistic peptide
- seq
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410158687.1A CN103936833B (zh) | 2014-04-18 | 2014-04-18 | BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410158687.1A CN103936833B (zh) | 2014-04-18 | 2014-04-18 | BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103936833A true CN103936833A (zh) | 2014-07-23 |
CN103936833B CN103936833B (zh) | 2016-02-10 |
Family
ID=51184736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410158687.1A Expired - Fee Related CN103936833B (zh) | 2014-04-18 | 2014-04-18 | BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103936833B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105949306A (zh) * | 2016-06-19 | 2016-09-21 | 苏州普罗达生物科技有限公司 | 一种b/t淋巴细胞弱化因子免疫原多肽及其用途 |
CN106220740A (zh) * | 2016-08-18 | 2016-12-14 | 中山大学 | 可溶性蛋白baff在b细胞体外培养及扩增的应用 |
CN105919989B (zh) * | 2016-06-08 | 2019-01-18 | 天津大学 | (2R,3R)-二苯甲酰酒石酸在制备BLyS拮抗剂的用途 |
CN110982824A (zh) * | 2019-10-09 | 2020-04-10 | 天津大学 | 拮抗pd-1的抗体类似物bp基因及蛋白和应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1781936A (zh) * | 2004-12-03 | 2006-06-07 | 中国人民解放军第三军医大学 | B淋巴细胞刺激因子抑制肽及其筛选、制备方法 |
CN1793178A (zh) * | 2005-11-17 | 2006-06-28 | 中国人民解放军第四军医大学 | 破伤风毒素t细胞表位多肽与人b淋巴细胞刺激因子融合蛋白及其制备 |
WO2006083961A2 (en) * | 2005-02-01 | 2006-08-10 | Research Development Foundation | Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
CN1835972A (zh) * | 2003-06-05 | 2006-09-20 | 健泰科生物技术公司 | B细胞疾病的联合治疗 |
WO2008119042A2 (en) * | 2007-03-27 | 2008-10-02 | Zymogenetics, Inc. | Combination of blys inhibition and/or april inhibition and immunnosuppressants for treatment of autoimmune disease |
CN101323643A (zh) * | 2007-06-15 | 2008-12-17 | 烟台荣昌生物工程有限公司 | 优化的TACI-Fc融合蛋白 |
-
2014
- 2014-04-18 CN CN201410158687.1A patent/CN103936833B/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1835972A (zh) * | 2003-06-05 | 2006-09-20 | 健泰科生物技术公司 | B细胞疾病的联合治疗 |
CN1781936A (zh) * | 2004-12-03 | 2006-06-07 | 中国人民解放军第三军医大学 | B淋巴细胞刺激因子抑制肽及其筛选、制备方法 |
WO2006083961A2 (en) * | 2005-02-01 | 2006-08-10 | Research Development Foundation | Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
WO2006083961A3 (en) * | 2005-02-01 | 2007-05-10 | Res Dev Foundation | Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
CN1793178A (zh) * | 2005-11-17 | 2006-06-28 | 中国人民解放军第四军医大学 | 破伤风毒素t细胞表位多肽与人b淋巴细胞刺激因子融合蛋白及其制备 |
WO2008119042A2 (en) * | 2007-03-27 | 2008-10-02 | Zymogenetics, Inc. | Combination of blys inhibition and/or april inhibition and immunnosuppressants for treatment of autoimmune disease |
WO2008119042A3 (en) * | 2007-03-27 | 2009-04-30 | Zymogenetics Inc | Combination of blys inhibition and/or april inhibition and immunnosuppressants for treatment of autoimmune disease |
CN101323643A (zh) * | 2007-06-15 | 2008-12-17 | 烟台荣昌生物工程有限公司 | 优化的TACI-Fc融合蛋白 |
Non-Patent Citations (2)
Title |
---|
JIAN SUN ET AL: "A novel BLyS antagonist peptide designed based on the 3-D complex structure of BCMA and BLyS", 《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》 * |
YU TIAN ET AL: "An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA", 《BIOTECHNOL LETT》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105919989B (zh) * | 2016-06-08 | 2019-01-18 | 天津大学 | (2R,3R)-二苯甲酰酒石酸在制备BLyS拮抗剂的用途 |
CN105949306A (zh) * | 2016-06-19 | 2016-09-21 | 苏州普罗达生物科技有限公司 | 一种b/t淋巴细胞弱化因子免疫原多肽及其用途 |
CN106220740A (zh) * | 2016-08-18 | 2016-12-14 | 中山大学 | 可溶性蛋白baff在b细胞体外培养及扩增的应用 |
CN110982824A (zh) * | 2019-10-09 | 2020-04-10 | 天津大学 | 拮抗pd-1的抗体类似物bp基因及蛋白和应用 |
CN110982824B (zh) * | 2019-10-09 | 2022-04-15 | 天津大学 | 拮抗pd-1的抗体类似物bp基因及蛋白和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103936833B (zh) | 2016-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103936833B (zh) | BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白 | |
Santner et al. | Sweeping away protein aggregation with entropic bristles: intrinsically disordered protein fusions enhance soluble expression | |
Bahia et al. | Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory-and immune-related disorders | |
Benoit et al. | The x-ray crystal structure of the first RNA recognition motif and site-directed mutagenesis suggest a possible HuR redox sensing mechanism | |
CN103965295B (zh) | BLyS拮抗肽、含TA-Fc融合蛋白基因的质粒及TA-Fc融合蛋白 | |
KR20140007394A (ko) | 면역 글로불린 결합성 신규 폴리펩티드 | |
US8268635B2 (en) | Methods of identifying agents that selectively activate p38 and/or NKkB signaling | |
CN102373234A (zh) | 一种内含肽介导的类弹性蛋白纯化重组蛋白的方法 | |
Jones et al. | Developing therapeutic proteins by engineering ligand–receptor interactions | |
CN103756983B (zh) | 一种天然哺乳动物尿酸酶制备方法 | |
Ware | Protein therapeutics targeted at the TNF superfamily | |
CN101280001B (zh) | 人SDF-1α的制备及由此获得的人SDF-1α及其用途 | |
CN104193806A (zh) | BLyS拮抗肽SS12、含该拮抗肽的融合蛋白SS12-Fc及基因 | |
CN103360497A (zh) | 一种新型抗肿瘤融合蛋白疫苗及其制备方法和应用 | |
CN107090426A (zh) | 一种重组mGM-CSF与GnRH融合蛋白的基因工程菌的构建 | |
CN102241776B (zh) | Rankl-tnf样区融合蛋白及其制备方法和应用 | |
You et al. | Molecular cloning, expression, bioinformatics analysis and bioactivity characterization of TNF13B (BAFF) gene in bat (Vespertilio superans Thomas) | |
Zhang et al. | Molecular and functional characterization of BAFF from the Yangtze alligator (Alligator sinensis, Alligatoridae) | |
CN113817027A (zh) | 一种牛疱疹病毒Ⅰ型gE蛋白胞外区的原核可溶性表达方法 | |
Fang et al. | High-Level Prokaryotic Expression and Purification of Death Domain Superfamily with MBP Tag. | |
CN103145852B (zh) | 一种重组人多功能生长因子Pleiotrophin融合蛋白及其制备方法 | |
CN105919989B (zh) | (2R,3R)-二苯甲酰酒石酸在制备BLyS拮抗剂的用途 | |
Yang et al. | Characterization of the molecular structure, expression and bioactivity of the TNFSF13B (BAFF) gene of the South African clawed frog, Xenopus laevis | |
CN111909267B (zh) | 低免疫原性抗TNF-α人源化单克隆抗体TCX063及其应用 | |
CN108707196A (zh) | 一种人肿瘤坏死因子ⅰ型受体胞外区蛋白的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Sun Jian Inventor after: Zhao Yacong Inventor after: Bai Wurentuya Inventor after: Ji Lijun Inventor after: Hao Xiafei Inventor before: Sun Jian Inventor before: Feng Jiannan Inventor before: Shen Beifen Inventor before: Zhao Yacong Inventor before: Bai Wurentuya Inventor before: Ji Lijun Inventor before: Hao Xiafei |
|
CB03 | Change of inventor or designer information | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160210 Termination date: 20210418 |
|
CF01 | Termination of patent right due to non-payment of annual fee |